202 related articles for article (PubMed ID: 23264357)
1. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus.
Badot V; Luijten RK; van Roon JA; Depresseux G; Aydin S; Van den Eynde BJ; Houssiau FA; Lauwerys BR
Ann Rheum Dis; 2013 Mar; 72(3):453-6. PubMed ID: 23264357
[TBL] [Abstract][Full Text] [Related]
2. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
3. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
5. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
6. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
[TBL] [Abstract][Full Text] [Related]
7. [Expression of interleukin-6 and its receptors in peripheral blood of patients with systemic lupus erythematosus].
Liu X; Lin H; Yuan G; Huang F
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):448-50. PubMed ID: 11798678
[TBL] [Abstract][Full Text] [Related]
8. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.
Chi S; Xue J; Li F; Zhu C; Yu Y; Li H; Wang X; Zhang Y; Yang J; Zhou S; Yang L; Ji C; Liu X
Autoimmune Dis; 2016; 2016():8252605. PubMed ID: 27069677
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus.
El-Shafey EM; El-Nagar GF; El-Bendary AS; Sabry AA; Selim AG
Iran J Kidney Dis; 2008 Apr; 2(2):80-5. PubMed ID: 19377213
[TBL] [Abstract][Full Text] [Related]
11. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.
Badot V; Durez P; Van den Eynde BJ; Nzeusseu-Toukap A; Houssiau FA; Lauwerys BR
J Cell Mol Med; 2011 Nov; 15(11):2335-42. PubMed ID: 21129157
[TBL] [Abstract][Full Text] [Related]
13. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
14. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor levels in lupus nephritis.
Laut J; Senitzer D; Petrucci R; Sablay LB; Barland P; Glicklich D
Clin Nephrol; 1992 Oct; 38(4):179-84. PubMed ID: 1424303
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.
Abbas D; Ezzat Y; Hamdy E; Gamil M
Lupus; 2012 Jan; 21(1):103-10. PubMed ID: 21976404
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
19. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]